• Richard B. BrooksEmail author


In the past, HIV was often detected late in the disease course and management consisted primarily of treating associated opportunistic infections. With better surveillance and the development of more effective antiretroviral medications with fewer toxic side effects, HIV is in many ways now viewed as a chronic illness requiring long-term management. Despite these advances, an estimated 21% of HIV-infected individuals are unaware of their infection.1 More attention has therefore been focused on identifying these individuals through screening and targeted testing.


Viral Load Opportunistic Infection Adrenal Insufficiency Elevated Viral Load High Postoperative Complication Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1. 
    CDC. HIV prevalence estimates–United States, 2006. MMWR. 2008;57[No. 39]:1073–1076.Google Scholar
  2. 2. 
    Desquilbet L, Jacobson L, Fried LP, et al. Multicenter AIDS cohort study. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol Biol Sci Med Sci. 2007;62A:1279-86.Google Scholar
  3. 3. 
    CDC. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR. 2005;54[No. RR-09]: 1–17.Google Scholar
  4. 4. 
    Horberg MA, Hurley LB, Klein DB, et al. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Arch Surg. 2006;141:1238-45.PubMedCrossRefGoogle Scholar
  5. 5. 
    Morrison CA, Wyatt WM, Carrick MM. Effects of human immunodeficiency virus status on trauma outcomes: a review of the national trauma database. Surg Infect. 2010;11:41-7.CrossRefGoogle Scholar
  6. 6. 
    Habermann B, Eberhardt C, Kurth AA. Total joint replacements in HIV positive patients. J Infect. 2008;57:41-6.PubMedCrossRefGoogle Scholar
  7. 7. 
    Louis J, Landon MB, Gersnoviez RJ, et al. Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet Gynecol. 2007;110:385-90.PubMedCrossRefGoogle Scholar
  8. 8. 
    Blumberg EA, Stock P. The AST Infectious Diseases Community of Practice. Solid organ transplantation in the HIV-infected patient. Am J Transplant. 2009;9:S131-S135.PubMedCrossRefGoogle Scholar
  9.  9. 
    CDC. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55[No. RR-14]:1–17.Google Scholar
  10. 10. 
    Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993;328:1670-1674.PubMedCrossRefGoogle Scholar
  11. 11. 
    Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of ­antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 10, 2011; 1–161. Available at Accessed 5/7/10.
  12. 12. 
    Perinatal HIV Guidelines Working Group. Public Health Service Task Force. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected. Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. May 24, 2010; pp 1–90. Available at Accessed 3/3/10.
  13. 13. 
    Kuritzkes DR, Parenti D, Ward DJ, et al. Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group. AIDS. 1998;12:65-74.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Department of MedicineUniversity of California, San Francisco General HospitalSan FranciscoUSA

Personalised recommendations